Articles From: Actavis Net Revenue Increases 40% to $2.66 Billion in First Quarter 2014; Non-GAAP EPS Increases 75% to $3.49 to Adherex Provides Corporate Update and First Quarter Ended March 31, 2014 Financial Results


- First Quarter 2014 GAAP Earnings Per Diluted Share of $0.55 - - 86% Increase in First Quarter 2014 Adjusted EBITDA to $860 million - DUBLIN , April 30, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today reported net revenue increased 40 percent to $2.66 billion for the first quarter ended March 31, 2014 , compared to $1.90 billion in the first quarter 2013.
Sign-up for Actavis Net Revenue Increases 40% to $2.66 Billion in First Quarter 2014; Non-GAAP EPS Increases 75% to $3.49 investment picks
DUBLIN , May 22, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that, subject to the close of its pending acquisition (the "Acquisition") of Forest Laboratories, Inc. (NYSE: FRX) , it is offering to guarantee certain of Forest's outstanding debt securities in exchange for the elimination of the existing registration rights obligations with respect to those outstanding debt securities.
Sign-up for Actavis Offers to Guarantee Certain Forest Laboratories Senior Notes in connection with Forest Consent Solicitations investment picks
DUBLIN , May 13, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for a generic version of Mallinckrodt Inc.'s Exalgo ® (Hydromorphone Hydrochloride Extended-release Tablets 8 mg, 12 mg and 16 mg). Actavis intends to begin shipping its product shortly and believes that, under applicable Hatch Waxman rules, it may be entitled to marketing exclusivity.
Sign-up for Actavis Receives Final Approval for Generic Version of Exalgo® investment picks
DUBLIN , April 28, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that its subsidiary, Watson Laboratories, Inc., has filed suit against the U.S. Food and Drug Administration (FDA) challenging the Agency's decision regarding its entitlement to shared 180-day marketing exclusivity for its generic version of Celebrex ® (celecoxib) 50 mg, 100 mg, 200 mg and 400 mg capsules.
Sign-up for Actavis Sues FDA Regarding Delay of Generic Celebrex® Approval investment picks
DUBLIN , May 21, 2014 /PRNewswire/ -- Actavis plc (NYSE:ACT) , a leading global specialty pharmaceutical company, today announced that Paul Bisaro , Chairman and CEO of Actavis, will provide an overview and update of the Company's business at the Goldman Sachs 35 th Annual Global Healthcare Conference 2014 in Rancho Palos Verdes, California .
Sign-up for Actavis to Present at Goldman Sachs 35th Annual Global Healthcare Conference 2014 investment picks
DUBLIN , May 13, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) , a leading global specialty pharmaceutical company, today announced that Paul Bisaro , Chairman and CEO of Actavis, will provide an overview and update of the Company's business at the Sanford C.
Sign-up for Actavis to Present at Sanford C. Bernstein Thirtieth Annual Strategic Decisions Conference 2014 investment picks
ZHUHAI, China , May 6, 2014 /PRNewswire/ -- Actions Semiconductor Co., Ltd.
Sign-up for Actions Semiconductor Announces Annual General Meeting Results investment picks
ZHUHAI, China , May 6, 2014 /PRNewswire/ -- Actions Semiconductor Co., Ltd.
Sign-up for Actions Semiconductor Reports First Quarter 2014 Results investment picks
http://media.marketwire.com/attachments/201202/12010_ActivePowerLogoHighRes.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1117628&ProfileId=051205&sourceType=1 AUSTIN, TX --
Sign-up for Active Power CTO to Address The Green Grid Agreement on Data Centre Energy Productivity at Datacentres Europe investment picks
http://media.marketwire.com/attachments/201202/12010_ActivePowerLogoHighRes.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1110443&ProfileId=051205&sourceType=1 AUSTIN, TX --
Sign-up for Active Power Reports First Quarter 2014 Results investment picks
2014/4/30
LOS ANGELES (MarketWatch) -- British actor Bob Hoskins died Tuesday at age 71 after suffering from pneumonia, according to reports citing a statement from his family a day after his death.
Sign-up for Actor Bob Hoskins dead at 71 investment picks
http://media.marketwire.com/attachments/201209/51329_acura.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1112379&ProfileId=051205&sourceType=1 PALATINE, IL --
Sign-up for Acura Pharmaceuticals Announces First Quarter 2014 Financial Results investment picks
http://media.marketwire.com/attachments/201209/51329_acura.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1113417&ProfileId=051205&sourceType=1 PALATINE, IL --
Sign-up for Acura Pharmaceuticals Announces Settlement of Patent Litigation With Ranbaxy Inc. investment picks
http://media.marketwire.com/attachments/201209/51329_acura.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1117632&ProfileId=051205&sourceType=1 PALATINE, IL --
Sign-up for Acura Pharmaceuticals Announces Settlement of Patent Litigation With Sandoz Inc. investment picks
http://media.marketwire.com/attachments/201209/51329_acura.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1110312&ProfileId=051205&sourceType=1 PALATINE, IL --
Sign-up for Acura Pharmaceuticals to Host First Quarter 2014 Financial Results Conference Call on May 6, 2014 investment picks
Acxiom® Corporation (Nasdaq:ACXM) expects to issue its FY 2014 fourth quarter and full year earnings release on Wednesday, May 14, after the financial markets close.
Sign-up for Acxiom to Discuss Fourth Quarter Earnings investment picks
2014/5/19
By Jack Marshall Advertising holding company Publicis Groupe and social-networking service Facebook have struck a major multiyear partnership, Publicis announced Monday.
Sign-up for Ad giant Publicis and Facebook ink partnership deal investment picks
EMERYVILLE, Calif.
Sign-up for Adamas Reports First Quarter 2014 Financial Results investment picks
2014/5/9
HOUSTON , May 9, 2014 /PRNewswire/ -- Adams Resources & Energy, Inc., (NYSE MKT - AE), announced first quarter 2014 unaudited net earnings of $5,363,000 or $1.27 per common share on revenues of $949,189,000 .
Sign-up for Adams Resources Announces First Quarter 2014 Earnings And Dividend investment picks
2014/5/1
ATLANTA , May 1, 2014 /PRNewswire/ -- AdCare Health Systems, Inc. (NYSE MKT: ADK) (NYSE MKT: ADK.PRA) (the "Company") announced that at 10 a.m. ET Thursday, May 8, 2014 , management will hold a conference call to discuss first quarter 2014 financial results.
Sign-up for AdCare Health Systems, Inc. Schedules Conference Call to Report First Quarter 2014 Financial Results investment picks
http://media.marketwire.com/attachments/201307/175415_Clipboard01.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1113491&ProfileId=051205&sourceType=1 CHICAGO, IL --
Sign-up for Additional U.S. Patent Highlights Mattersight's Unique Predictive Behavioral Routing Capabilities investment picks
2014/5/1
First Quarter Financial Highlights - Strong revenue growth despite challenging weather conditions - Total net service revenues of $71.7 million for a 13.8 percent increase compared to prior year quarter - Net income of $2.4 million, or $0.21 per diluted share.
Sign-up for Addus HomeCare Reports First Quarter 2014 Results investment picks
BROKEN ARROW, Okla., April 30, 2014 (GLOBE NEWSWIRE) -- ADDvantage Technologies Group, Inc. (Nasdaq:AEY) , announced today that it will release financial results for the three month period ended March 31, 2014, on Tuesday, May 13, 2014, before markets open.
Sign-up for ADDvantage Technologies Group, Inc. to Report Results for Fiscal Second Quarter 2014 investment picks
2014/5/23
LUXEMBOURG , May 23, 2014 /PRNewswire/ -- Adecoagro S.A. (NYSE: AGRO, Bloomberg: AGRO US , Reuters.
Sign-up for Adecoagro announces filing of annual report on form 20-F for year ended December 31, 2013 on April 30, 2014 investment picks
By Bradley Hope Nasdaq OMX Group Inc. has hired Adena Friedman as co-president as part of a broad restructuring of the company that positions the former exchange executive as the most likely to succeed Robert Greifeld in the top job.
Sign-up for Adena Friedman returns to Nasdaq from Carlyle investment picks
PLEASANTON, Calif., April 25, 2014 (GLOBE NEWSWIRE) -- Adept Technology, Inc. (Nasdaq:ADEP) , a leading provider of intelligent robots, autonomous mobile solutions and services, today announced that it will release the Company's financial results for the third quarter of 2014 on Thursday, May 8, 2014 after the close of market.
Sign-up for Adept Technology Announces Date and Time of Fiscal 2014 Third Quarter Financial Results Conference Call investment picks
PLEASANTON, Calif., April 10, 2014 (GLOBE NEWSWIRE) -- Adept Technology, Inc. (Nasdaq:ADEP) , a leading provider of intelligent robots, autonomous mobile solutions and services, today announced that John Villadsen has joined the company as Vice President of Global Operations.
Sign-up for Adept Technology Names John Villadsen Vice President of Global Operations investment picks
2014/5/16
EDMOND, Okla.
Sign-up for ADFITECH Announces Stock Buyback Plan investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0946303001&sourceType=1 http://media3.marketwire.com/logos/20131114-adherex-lg.jpg RESEARCH TRIANGLE PARK, NORTH CAROLINA --
Sign-up for Adherex Provides Corporate Update and First Quarter Ended March 31, 2014 Financial Results investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Actavis Net Revenue Increases 40% to $2.66 Billion in First Quarter 2014; Non-GAAP EPS Increases 75% to $3.49 to Adherex Provides Corporate Update and First Quarter Ended March 31, 2014 Financial Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry